Concepedia

Francesco Merolla

FM

Statistics

Publications

37

Citations

1.4K

H-Index

24

Active since

2004

Affiliations

University of Naples Federico II(Current)

Institute for Experimental Endocrinology and Oncology

University of Molise

Federico II University Hospital

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Francesco Merolla is an author at University of Naples Federico II specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2004–2025

37

Publications

37

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells

Erika Martinelli, Teresa Troiani, Elena D’Aiuto et al. · International Journal of Cancer · 2013 · 91 citations · Full text

, , +15

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells

Francesco Morra, Francesco Merolla, Virginia Napolitano et al. · Oncotarget · 2017 · 75 citations · Full text

, , +15

Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab

Stefania Napolitano, Giulia Martini, Barbara Rinaldi et al. · Clinical Cancer Research · 2015 · 72 citations

, , +15

NCOA4 Transcriptional Coactivator Inhibits Activation of DNA Replication Origins

Roberto Bellelli, Maria Domenica Castellone, Teresa Guida et al. · Molecular Cell · 2014 · 69 citations · Full text

, , +12

USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs

Umberto Malapelle, Francesco Morra, Gennaro Ilardi et al. · Lung Cancer · 2016 · 65 citations

, , +9

1–5 of 37